Current demand for SARS‐CoV‐2 testing is straining material resource and labor capacity around the globe. As a result, the public health and clinical community are hindered in their ability to monitor and contain the spread of COVID‐19. Despite broad consensus that more testing is needed, pragmatic guidance towards ...
‘All In’: A Pragmatic Framework for COVID‐19 Testing and Action on a Global Scale
EMBO Molecular Medicine, 2020